title: Evaluation of current biologic meshes in pelvic organ prolapse repair.
abstract: Pelvic organ prolapse (POP) is a common disorder estimated to affect 15%-30% of women over the age of 50 years. About 11% of women will require surgery by the age of 80 years and there is an estimated 30% rate of prolapse recurrence. In an attempt to improve surgical outcomes, biologic grafts and synthetic meshes have been implemented in the repair of POP. Biologic grafts have been used with the hope of avoiding complications associated with synthetic mesh. This presents the existing data surrounding the use of biologic grafts in the surgical repair of anterior compartment, vaginal vault, and posterior compartment prolapse.
authors.affiliation: University of Toronto, Sunnybrook Health Sciences Centre, ON, Canada.
authors.forename: Ashley
authors.initials: A
authors.lastname: Cox
authors.forename: Sender
authors.initials: S
authors.lastname: Herschorn
mesh_terms: D001672:Biocompatible Materials / Q000627:therapeutic use; D052858:Cystocele / Q000601:surgery; D004414:Dyspareunia / Q000209:etiology; D005260:Female; D006801:Humans; D056887:Pelvic Organ Prolapse / Q000601:surgery*; D011126:Polypropylenes; D013526:Surgical Mesh; D014183:Transplantation, Heterologous; D014184:Transplantation, Homologous; D014596:Uterine Prolapse / Q000601:surgery
chemical_list: D001672:Biocompatible Materials; D011126:Polypropylenes